We are delighted to announce that Sisram Medical spinned off by Shanghai Fosun Pharmaceutical, the first ever Israeli company to list on the Hong Kong Stock Exchange, has been awarded China Deal of the Year 2017, by China Business Law Journal.
On September 19, Fosun International and Fosun Pharma, advised jointly by Dentons' Hong Kong and Shanghai offices, spun off and listed their overseas subsidiary, Sisram Medical Ltd., on the Main Board of the Stock Exchange of Hong Kong. The global offering of 110,000,000 shares raised total proceeds of US$125 million.
The Dentons Hong Kong team was led by Capital Markets Partners Gordon Ng and Enoch Wong, acted as the legal counsel of the joint sponsors and underwriters.
Redefining possibilities. Together, everywhere. For more information visit dentons.com
heading